Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Volitionrx (VNRX) Net Margin (2019 - 2025)

Volitionrx filings provide 8 years of Net Margin readings, the most recent being 6910.5% for Q4 2025.

  • On a quarterly basis, Net Margin fell 2279102.0% to 6910.5% in Q4 2025 year-over-year; TTM through Dec 2025 was 443.08%, a 243521.0% increase, with the full-year FY2025 number at 11.46%, up 269383.0% from a year prior.
  • Net Margin hit 6910.5% in Q4 2025 for Volitionrx, down from 5.84% in the prior quarter.
  • In the past five years, Net Margin ranged from a high of 15880.52% in Q4 2024 to a low of 6910.5% in Q4 2025.
  • Median Net Margin over the past 5 years was 0.77% (2025), compared with a mean of 936.34%.
  • Biggest five-year swings in Net Margin: surged 190783461bps in 2021 and later tumbled -2279102bps in 2025.
  • Volitionrx's Net Margin stood at 513.26% in 2021, then plummeted by -85bps to 78.6% in 2022, then plummeted by -4636bps to 3565.25% in 2023, then skyrocketed by 545bps to 15880.52% in 2024, then tumbled by -144bps to 6910.5% in 2025.
  • The last three reported values for Net Margin were 6910.5% (Q4 2025), 5.84% (Q3 2025), and 7.37% (Q2 2025) per Business Quant data.